Nasdaq
INAB
IN8bio, Inc.
- Health Care
- Listed 2021
- 1 day
- −1.9%
- 1 month
- −30.2%
- 1 year
- −53.8%
$0.9699 · Mkt cap $9.55M
At the 6 Aug 2026 close
Nasdaq
IN8bio, Inc.
$0.9699 · Mkt cap $9.55M
At the 6 Aug 2026 close
IN8bio, Inc. trades under the ticker INAB on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2021. Its market capitalisation is $9.55M. The last closing price was $0.9699, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −53.8%, and −30.2% over the past month. Returns are price returns and exclude dividends.
This page exists because INAB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.